A Low Postoperative Nonstimulated Serum Thyroglobulin Level Does Not Exclude the Presence of Radioactive Iodine Avid Metastatic Foci in Intermediate-Risk Differentiated Thyroid Cancer Patients

被引:51
|
作者
Robenshtok, Eyal [1 ,3 ]
Grewal, Ravinder K. [2 ]
Fish, Stephanie [1 ]
Sabra, Mona [1 ]
Tuttle, R. Michael [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Serv Endocrinol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Div Nucl Med, Dept Radiol, New York, NY 10021 USA
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
UNDETECTABLE THYROGLOBULIN; I-131; ABLATION; CARCINOMA; TG;
D O I
10.1089/thy.2012.0352
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Postsurgical thyrotropin (TSH)-stimulated serum thyroglobulin (Tg) level can be used to predict the likelihood of finding radioactive iodine (RAI) avid metastatic foci on postablation scanning. However, there is little data regarding the predictive value of a nonstimulated postoperative Tg obtained on levothyroxine therapy in patients being considered for recombinant human TSH (rhTSH)-assisted remnant ablation. Methods: The study included 290 intermediate-risk differentiated thyroid cancer (DTC) patients with a postsurgical nonstimulated Tg < 10 ng/mL prior to rhTSH-assisted remnant ablation. Patients were stratified into four groups based on the postsurgical nonstimulated Tg value: Tg < 0.6 ng/mL (n = 146), Tg 0.6-0.9 ng/mL (n = 76), Tg 1-5 ng/mL (n = 51), and Tg > 5-10 ng/mL (n = 17). RAI avid metastatic foci were identified using post-therapy scanning with SPECT/CT (single photon emission computed tomography). Results: RAI avid metastases were identified in 16% (46/290) of patients, including 12% (17/146) with Tg < 0.6 ng/mL, 14% (11/76) with Tg 0.6-0.9 ng/mL, 25% (13/51) with Tg 1-5 ng/mL, and 29% (5/17) with Tg > 5-10 ng/mL (p = 0.02). While 99% of the RAI avid foci were located in the neck, lung uptake was seen in one patient with Tg < 0.6 ng/mL (0.7%, 1/146), one patient with Tg 0.6-0.9 ng/mL (1.3%, 1/76), and 2 patients with Tg > 5-10 ng/mL (11%, 2/17 patients). Conclusions: A postoperative nonstimulated Tg < 0.6 ng/mL does not exclude identification of RAI avid metastatic foci on postablation SPECT/CT scanning in intermediate-risk DTC patients. Therefore, patient selection for RAI ablation in the intermediate-risk group must be based on an integration of multiple risk factors rather than any single clinicopathologic risk factor.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 50 条
  • [1] Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma
    Pedro Weslley Rosario
    [J]. Annals of Surgical Oncology, 2019, 26 : 867 - 868
  • [2] Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma
    Rosario, Pedro Weslley
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S867 - S868
  • [3] Reply to: Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma
    McDow, Alexandria D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S869 - S870
  • [4] Reply to: Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma
    Alexandria D. McDow
    [J]. Annals of Surgical Oncology, 2019, 26 : 869 - 870
  • [5] Efficacy of adjuvant therapy with 3.7GBq radioactive iodine in intermediate-risk patients with 'higher risk features' and predictive value of postoperative nonstimulated thyroglobulin
    Rosario, Pedro W.
    Mourao, Gabriela F.
    Calsolari, Maria Regina
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) : 1148 - 1153
  • [6] Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
    Zhao, Hengqiang
    Gong, Yiping
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer
    Nixon, Iain J.
    Ganly, Ian
    [J]. FUTURE ONCOLOGY, 2013, 9 (07) : 921 - 923
  • [8] A low postoperative nonstimulated serum thyroglobulin level excludes the presence of persistent disease in low-risk papillary thyroid cancer patients: implication for radioiodine indication
    Rosario, Pedro W.
    Mourao, Gabriela F.
    Siman, Thassio Leonardo
    Calsolari, Maria Regina
    [J]. CLINICAL ENDOCRINOLOGY, 2015, 83 (06) : 957 - 961
  • [9] The diagnostic value of stimulated serum thyroglobulin in the follow-up of low and intermediate-risk patients with differentiated thyroid cancer
    Mihaljevic, I.
    Wagenhofer, V.
    Kralj, T.
    Vrdoljak, D.
    Kizivat, T.
    Mudri, D.
    Franceschi, M.
    Jukic, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S699 - S700
  • [10] The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
    Wang, Xiaofei
    Zhu, Jingqiang
    Li, Zhihui
    Wei, Tao
    [J]. PLOS ONE, 2020, 15 (06):